GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affimed NV (NAS:AFMD) » Definitions » 3-Year Revenue Growth Rate

Affimed NV (Affimed NV) 3-Year Revenue Growth Rate : -47.30% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Affimed NV 3-Year Revenue Growth Rate?

Affimed NV's Revenue per Share for the three months ended in Dec. 2023 was $0.03.

During the past 12 months, Affimed NV's average Revenue per Share Growth Rate was -80.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -47.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was -26.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was -2.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of Affimed NV was 96.60% per year. The lowest was -47.30% per year. And the median was -5.10% per year.


Competitive Comparison of Affimed NV's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Affimed NV's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Affimed NV's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affimed NV's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Affimed NV's 3-Year Revenue Growth Rate falls into.



Affimed NV 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Affimed NV  (NAS:AFMD) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Affimed NV 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Affimed NV's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Affimed NV (Affimed NV) Business Description

Industry
Traded in Other Exchanges
Address
Im Neuenheimer Feld 582, Technologiepark, Heidelberg, BW, DEU, 69120
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.

Affimed NV (Affimed NV) Headlines

From GuruFocus

Affimed Reports on Corporate Progress and Provides Regulatory Update for AFM13

By Stock market mentor Stock market mentor 01-09-2023